Anaphylaxis

Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman

inVentiv adds new comms exec; Julie Bowen teams up with Mylan for allergy emergencies; Royalty raises the bid on Elan; Pfizer nixes non-Hodgkin's lymphoma drug in trials.

Dey launches EpiPen app

Dey launches EpiPen app

By

Mylan's Dey Pharma launched MyEpiPen App, designed to help patients with severe allergies and their caregivers cope with episodes of anaphylaxis.

Email Newsletters